ArticleFrontiers in immunology2026

Correction: IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.